Knockdown of ATP1A1 expression remarkably reduced the proliferation and migration and increased apoptosis in human HCC cells in vitro and impaired their tumorigenicity in vivo, further indicating that ATP1A1 plays an important role in HCC development and is a potential target for HCC treatment. This evidence concerns the gene ATP1A1 and hepatocellular carcinoma.